• Most Popular
  • Most Shared

RIM shares sag on brokerage reports

TORONTO
Mon Oct 20, 2008 5:32pm EDT
Jim Balsillie, co-chief executive of Research In Motion (RIM), holds the new Blackberry Bold handset during its launch in Mumbai September 18, 2008. REUTERS/Punit Paranjpe

Jim Balsillie, co-chief executive of Research In Motion (RIM), holds the new Blackberry Bold handset during its launch in Mumbai September 18, 2008.

Credit: Reuters/Punit Paranjpe

TORONTO (Reuters) - Research In Motion shares fell as much as 10 percent on Monday after one brokerage said retail sales trends for its BlackBerry smartphones in North America and Western Europe were weaker than hoped and another cut its earnings forecasts.

Hot Stocks

In a note on Monday, Pacific Crest Securities analyst James Faucette said so-called "sell-through" trends throughout the middle of October had been "slightly disappointing".

He also said risks to November-quarter results were building as the company becomes more reliant on "aggressive and successful" launches of its BlackBerry Storm and BlackBerry Bold models in the United States.

"In order to hit the company guidance, these new products have to be more successful," Faucette said.

As well, early sales of the BlackBerry Pearl Flip have been tepid at best and sales execution problems in Canada and Britain are plaguing Curve and Bold sales, he said.

Also on Monday, brokerage Morgan Keegan & Co Inc downgraded its revenue and earnings outlook for RIM, citing the "substantial worldwide damage" to the broader economic outlook since September.

In a note, analyst Tavis McCourt forecast RIM's revenue in 2009 of $11.08 billion, revised down from $11.55 billion, and $17.31 billion in 2010, down from $19.58 billion.

For earnings, McCourt sees $3.47 a share in 2009, revised down from $3.75, and $4.49 in 2010, down from $5.84.

RIM shares closed down 7.6 percent at C$64.88 on the Toronto Stock Exchange on Monday, after earlier dipping as low as C$63.25. On Nasdaq, they closed down 8.6 percent at $53.91.

RIM shares, which were worth more than $145 on Nasdaq about four months ago, have been dragged down by the U.S. financial crisis and by margin pressures due to expenses related to the launch of new smartphones.

"People are ratcheting back their expectations for earnings," said Peter Misek, an analyst at Canaccord Adams. "It's a pretty direct relationship when you see consensus estimates come down."

On October 8, Misek cut his outlook on RIM, citing an array of possible pressures, including a deterioration in the global economy, tougher competition and delays in penetrating new geographic markets.

However, he upgraded RIM's stock rating to "buy" from "hold."

"We said to ourselves the stock in a worst-case scenario is worth $50," said Misek. "In a more moderate scenario, it is worth $72.75 to $75. That prompted us to upgrade."

Paradigm analyst Barry Richards said it was too soon to make any assessment of what will happen to RIM's results.

"With the Bold, the Flip and the Storm all set to ramp in the back half of October and through November it is too early to make any assessment of the potential for Q3 or Q4 results," Richards wrote in a midday note.

($1=$1.19 Canadian)

(Reporting by Jennifer Kwan; editing by Rob Wilson)



More from Reuters

U.S. Speaker of the House Nancy Pelosi (C) is surrounded by reporters as she walks towards the U.S. House of Representatives chamber to begin the vote on health care reform on Capitol Hill in Washington, March 21, 2010. REUTERS/Larry Downing

Democrats face dubious voters

Democrats in Congress who passed historic legislation to revamp the healthcare system face a new challenge: convincing voters it's a good deal.  Full Article | Video 

A soldier guards hundreds of bags of wheat seed in the isolated district of Nad Ali's district centre in the west of Helmand province, October 17, 2009

Dirty money and Afghan war

As the war in Afghanistan enters its ninth year, the U.S. has finally realized the best way to stop the conflict is to cut the flow of drug money, columnist Bernd Debusmann writes.   Commentary 

    An H1N1 flu vaccine inoculation is given at the Geisinger Medical Center in Danville, Pennsylvania October 28, 2009. REUTERS/Brad Bower

    A new stab at conquering pain

    Millions of people worldwide suffer chronic pain that can last weeks, months or years but relief may be on the way.  Full Article